{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T02:02:13Z","timestamp":1771725733287,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017696","name":"Guangzhou Women and Children's Medical Center","doi-asserted-by":"publisher","award":["[2024]286"],"award-info":[{"award-number":["[2024]286"]}],"id":[{"id":"10.13039\/100017696","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.115894","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T08:35:36Z","timestamp":1764405336000},"page":"115894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["m6A-Related SNPs in endometriosis and ovarian cancer: implications for chemoresistance and therapeutic targeting"],"prefix":"10.1016","volume":"168","author":[{"given":"Ting","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao Qing","family":"She","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu Yang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng Shi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian Xiang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen Jiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115894_bb0005","doi-asserted-by":"crossref","unstructured":"Konstantinopoulos PA, Matulonis UA. Clinical and translational advances in ovarian cancer therapy. Nat. Cancer 2023 4(9):1239\u20131257. doi:https:\/\/doi.org\/10.1038\/s43018-023-00617-9. Epub 2023 Aug 31. PMID: 37653142.","DOI":"10.1038\/s43018-023-00617-9"},{"key":"10.1016\/j.intimp.2025.115894_bb0010","doi-asserted-by":"crossref","unstructured":"Eisenhauer EA. Real-world evidence in the treatment of ovarian cancer. Ann. Oncol. 2017 Nov 1;28(suppl_8):viii61-viii65. doi:https:\/\/doi.org\/10.1093\/annonc\/mdx443. (PMID: 29232466).","DOI":"10.1093\/annonc\/mdx443"},{"issue":"13","key":"10.1016\/j.intimp.2025.115894_bb0015","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.7150\/ijbs.100355","article-title":"Deubiquitinases in ovarian Cancer: role in drug resistance and tumor aggressiveness","volume":"20","author":"Beretta","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"10276","key":"10.1016\/j.intimp.2025.115894_bb0025","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(21)00389-5","article-title":"Endometriosis is a chronic systemic disease: clinical challenges and novel innovations","volume":"397","author":"Taylor","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.115894_bb0030","doi-asserted-by":"crossref","unstructured":"Vercellini P, Vigan\u00f2 P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat. Rev. Endocrinol. 2014 10(5):261\u201375. doi:https:\/\/doi.org\/10.1038\/nrendo.2013.255. Epub 2013 Dec 24. PMID: 24366116.","DOI":"10.1038\/nrendo.2013.255"},{"issue":"1","key":"10.1016\/j.intimp.2025.115894_bb0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s12967-023-04209-0","article-title":"METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing","volume":"21","author":"Wang","year":"2023","journal-title":"J. Transl. Med."},{"issue":"9","key":"10.1016\/j.intimp.2025.115894_bb0040","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.7150\/ijbs.69771","article-title":"Role of m6A modification in female infertility and reproductive system diseases","volume":"18","author":"Chen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2025.115894_bb0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41419-023-05866-1","article-title":"METTL3-dependent m6A methylation facilitates uterine receptivity and female fertility via balancing estrogen and progesterone signaling","volume":"14","author":"Wan","year":"2023","journal-title":"Cell Death Dis."},{"issue":"14","key":"10.1016\/j.intimp.2025.115894_bb0050","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.7150\/ijbs.81595","article-title":"Low expression of m6A reader YTHDC1 promotes progression of ovarian cancer via PIK3R1\/STAT3\/GANAB axis","volume":"19","author":"Wang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2025.115894_bb0070","doi-asserted-by":"crossref","unstructured":"Kr\u00e1l\u00ed\u010dkov\u00e1 M, Lagan\u00e0 AS, Ghezzi F, Vetvicka V. Endometriosis and risk of ovarian cancer: what do we know? Arch. Gynecol. Obstet. 2020 301(1):1\u201310. doi:https:\/\/doi.org\/10.1007\/s00404-019-05358-8. Epub 2019 Nov 19. PMID: 31745637.","DOI":"10.1007\/s00404-019-05358-8"},{"key":"10.1016\/j.intimp.2025.115894_bb0075","doi-asserted-by":"crossref","unstructured":"Wang Y, Nicholes K, Shih IM. The Origin and Pathogenesis of Endometriosis. Annu Rev Pathol. 2020 Jan 24;15:71\u201395. doi:https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012419-032654. Epub 2019 Sep 3. PMID: 31479615; PMCID: PMC7980953.","DOI":"10.1146\/annurev-pathmechdis-012419-032654"},{"issue":"6","key":"10.1016\/j.intimp.2025.115894_bb0080","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2217\/WHE.14.43","article-title":"Endometriosis and cancer","volume":"10","author":"Kr\u00e1l\u00ed\u010dkov\u00e1","year":"2014","journal-title":"Womens Health (Lond)."},{"key":"10.1016\/j.intimp.2025.115894_bb0085","doi-asserted-by":"crossref","unstructured":"Garcia-Alonso L, Handfield LF, Roberts K, Nikolakopoulou K, Fernando RC, Gardner L, Woodhams B, Arutyunyan A, Polanski K, Hoo R, Sancho-Serra C, Li T, Kwakwa K, Tuck E, Lorenzi V, Massalha H, Prete M, Kleshchevnikov V, Tarkowska A, Porter T, Mazzeo CI, van Dongen S, Dabrowska M, Vaskivskyi V, Mahbubani KT, Park JE, Jimenez-Linan M, Campos L, Kiselev VY, Lindskog C, Ayuk P, Prigmore E, Stratton MR, Saeb-Parsy K, Moffett A, Moore L, Bayraktar OA, Teichmann SA, Turco MY, Vento-Tormo R. Mapping the temporal and spatial dynamics of the human endometrium in vivo and in vitro. Nat Genet. 2021 Dec;53(12):1698\u20131711. doi:https:\/\/doi.org\/10.1038\/s41588-021-00972-2. Epub 2021 Dec 2. Erratum in: Nat Genet. 2023 Jan;55(1):165. doi:https:\/\/doi.org\/10.1038\/s41588-022-01287-6. PMID: 34857954; PMCID: PMC8648563.","DOI":"10.1038\/s41588-021-00972-2"},{"issue":"5","key":"10.1016\/j.intimp.2025.115894_bb0090","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/AOG.0000000000002580","article-title":"Ovarian Cancer prevention and screening","volume":"131","author":"Menon","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.intimp.2025.115894_bb0095","doi-asserted-by":"crossref","unstructured":"Konstantinopoulos PA, Matulonis UA. Clinical and translational advances in ovarian cancer therapy. Nat Cancer. 2023 4(9):1239\u20131257. doi:https:\/\/doi.org\/10.1038\/s43018-023-00617-9. Epub 2023 Aug 31. PMID: 37653142.","DOI":"10.1038\/s43018-023-00617-9"},{"key":"10.1016\/j.intimp.2025.115894_bb0100","doi-asserted-by":"crossref","unstructured":"Konstantinopoulos PA, Ceccaldi R, Shapiro GI, D'Andrea AD. Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer. Cancer Discov. 2015 Nov;5(11):1137\u201354. doi:https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0714. Epub 2015 Oct 13. PMID: 26463832; PMCID: PMC4631624.","DOI":"10.1158\/2159-8290.CD-15-0714"},{"issue":"1","key":"10.1016\/j.intimp.2025.115894_bb0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12943-024-01967-3","article-title":"Drug resistance in ovarian cancer: from mechanism to clinical trial","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"10177","key":"10.1016\/j.intimp.2025.115894_bb0110","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"issue":"10276","key":"10.1016\/j.intimp.2025.115894_bb0115","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(21)00389-5","article-title":"Endometriosis is a chronic systemic disease: clinical challenges and novel innovations","volume":"397","author":"Taylor","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.115894_bb0120","doi-asserted-by":"crossref","unstructured":"Bulun SE, Yildiz S, Adli M, Chakravarti D, Parker JB, Milad M, Yang L, Chaudhari A, Tsai S, Wei JJ, Yin P. Endometriosis and adenomyosis: shared pathophysiology. Fertil. Steril. 2023 119(5):746\u2013750. doi:https:\/\/doi.org\/10.1016\/j.fertnstert.2023.03.006. Epub 2023 Mar 15. PMID: 36925057.","DOI":"10.1016\/j.fertnstert.2023.03.006"},{"issue":"6","key":"10.1016\/j.intimp.2025.115894_bb0125","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/humupd\/dmab017","article-title":"Adenomyosis pathogenesis: insights from next-generation sequencing","volume":"27","author":"Bulun","year":"2021","journal-title":"Hum. Reprod. Update"},{"issue":"6","key":"10.1016\/j.intimp.2025.115894_bb0130","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/humrep\/dead071","article-title":"Targeting YAP1 ameliorates progesterone resistance in endometriosis","volume":"38","author":"Lin","year":"2023","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.intimp.2025.115894_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/rmb2.12588","article-title":"Progesterone resistance in endometriosis: a pathophysiological perspective and potential treatment alternatives","volume":"23","author":"Tang","year":"2024","journal-title":"Reprod. Med. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115894_bb0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12672-024-01040-x","article-title":"Interferon-induced transmembrane protein 2 is a prognostic marker in colorectal cancer and promotes its progression by activating the PI3K\/AKT pathway","volume":"15","author":"Liu","year":"2024","journal-title":"Discov. Oncol."},{"issue":"15","key":"10.1016\/j.intimp.2025.115894_bb0145","article-title":"Identifying hub genes in response to ustekinumab and the impact of ustekinumab treatment on fibrosis in Crohn\u2019s disease","author":"Xu","year":"2024","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115894_bb0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1167\/iovs.63.10.20","article-title":"METTL3 attenuates inflammation in fusarium solani-induced keratitis via the PI3K\/AKT Signaling pathway","volume":"63","author":"Huang","year":"2022","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692501882X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692501882X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T01:38:47Z","timestamp":1771724327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692501882X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"alternative-id":["S156757692501882X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115894","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"m6A-Related SNPs in endometriosis and ovarian cancer: implications for chemoresistance and therapeutic targeting","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115894"}}